$230.24
2.62% yesterday
NYSE, Dec 03, 10:12 pm CET
ISIN
US00287Y1091
Symbol
ABBV

AbbVie Stock price

$230.24
+18.28 8.62% 1M
+42.99 22.96% 6M
+52.54 29.57% YTD
+48.74 26.85% 1Y
+66.30 40.44% 3Y
+125.50 119.82% 5Y
+174.12 310.26% 10Y
+195.24 557.83% 20Y
NYSE, Closing price Wed, Dec 03 2025
+5.87 2.62%
ISIN
US00287Y1091
Symbol
ABBV
Industry

New AI Insights on AbbVie Insights AI Insights on AbbVie

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$406.9b
Enterprise Value
$470.0b
Net debt
$63.1b
Cash
$5.7b
Shares outstanding
1.8b
Valuation (TTM | estimate)
P/E
174.4 | 21.4
P/S
6.8 | 6.6
EV/Sales
7.9 | 7.6
EV/FCF
23.9
P/B
negative
Dividends
DPS
$6.65
Yield 1Y | 5Y
2.9% | 3.8%
Growth 1Y | 5Y
5.7% | 6.6%
Payout 1Y | 3Y
263.2% | 153.2%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$59.6b | $62.0b
EBITDA
$28.0b | $29.0b
EBIT
$19.7b | $27.7b
Net Income
$2.3b | $19.0b
Free Cash Flow
$19.7b
Growth (TTM | estimate)
Revenue
7.4% | 10.0%
EBITDA
17.3% | 16.6%
EBIT
27.4% | 68.1%
Net Income
-53.8% | 348.7%
Free Cash Flow
26.0%
Margin (TTM | estimate)
Gross
71.2%
EBITDA
46.9% | 46.8%
EBIT
33.1%
Net
3.9% | 30.7%
Free Cash Flow
33.0%
Financial Health
Equity Ratio
2.5%
Return on Equity
127.5%
ROCE
20.9%
ROIC
-
Debt/Equity
-26.0
More
EPS
$1.3
FCF per Share
$11.1
Short interest
1.1%
Employees
55k
Rev per Employee
$1.0m
Show more

Is AbbVie a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

AbbVie Stock Analysis

Unlock Scores for Free

Analyst Opinions

37 Analysts have issued a AbbVie forecast:

26x Buy
70%
11x Hold
30%

Analyst Opinions

37 Analysts have issued a AbbVie forecast:

Buy
70%
Hold
30%

Financial data from AbbVie

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
59,644 59,644
7% 7%
100%
- Direct Costs 17,201 17,201
5% 5%
29%
42,443 42,443
14% 14%
71%
- Selling and Administrative Expenses 13,970 13,970
0% 0%
23%
- Research and Development Expense 8,791 8,791
11% 11%
15%
27,967 27,967
17% 17%
47%
- Depreciation and Amortization 8,254 8,254
1% 1%
14%
EBIT (Operating Income) EBIT 19,713 19,713
27% 27%
33%
Net Profit 2,348 2,348
54% 54%
4%

In millions USD.

Don't miss a Thing! We will send you all news about AbbVie directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AbbVie Stock News

Neutral
Seeking Alpha
about 11 hours ago
AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Neutral
PRNewsWire
2 days ago
Data being presented showcases AbbVie's breadth and depth of research across a range of therapeutic modalities such as T-Cell Engagers, BCL-2 Inhibitors and Antibody-Drug Conjugates for a spectrum of difficult-to-treat blood cancers NORTH CHICAGO, Ill. , Dec. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Cong...
Neutral
The Motley Fool
2 days ago
Pfizer's strategy that will help it rebound from recent struggles is in full motion. It says a lot that the company continues to grow its dividend through tough times.
More AbbVie News

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Head office United States
CEO Robert Michael
Employees 55,000
Founded 2011
Website www.abbvie.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today